Pharmacological augmentation of endothelium-derived nitric oxide synthesis

GL Bakris - Journal of Managed Care Pharmacy, 2007 - jmcp.org
BACKGROUND: The sympathetic nervous system has a unique role in endothelial function,
and beta-receptors are a key part of sympathetic nervous system function. OBJECTIVE: To …

Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients

L Poirier, J Cléroux, A Nadeau… - Journal of …, 2001 - journals.lww.com
Objectives To compare the effects of nebivolol and atenolol in 25 ambulatory hypertensive
patients with impaired glucose tolerance. Design Clinic and ambulatory blood pressure …

Antihypertensive drugs and reversing of endothelial dysfunction in hypertension

S Taddei, A Virdis, L Ghiadoni, I Sudano… - Current hypertension …, 2000 - Springer
Essential hypertension is associated with impaired endothelium-dependent vasodilation
and is caused mainly by production of oxygen free radicals that can destroy nitric oxide …

[HTML][HTML] Endothelial nitric oxide synthase dysfunction in diabetic mice: importance of tetrahydrobiopterin in eNOS dimerisation

S Cai, J Khoo, S Mussa, NJ Alp, KM Channon - Diabetologia, 2005 - Springer
Aims/hypothesis Impaired nitric oxide (NO) bioactivity and increased superoxide (SO)
production are characteristics of vascular endothelial dysfunction in diabetes. The …

Endothelial cell dysfunction in type I and II diabetes: The cellular basis for dysfunction

M Pannirselvam, TJ Anderson… - Drug development …, 2003 - Wiley Online Library
Micro‐and macrovascular complications are the leading causes of mortality in Types I and II
diabetes. Hyperglycemia results in increased advanced glycosylation end (AGE) products …

Neither K+ channels nor PI3K/Akt mediates the vasodilative effect of nebivolol on different types of rat arteries

Y Wang, MS Zhang, Y Liu, J Li… - Journal of …, 2009 - journals.sagepub.com
Purpose: Nebivolol is a highly selective β1-adrenoceptor blocker with additional
vasodilating properties. It has been shown that the nebivolol-induced vasorelaxation is nitric …

Nebivolol: A Third-Generation β-Blocker That Augments Vascular Nitric Oxide Release: Endothelial β2-Adrenergic Receptor–Mediated Nitric Oxide Production

MAW Broeders, PA Doevendans, BCAM Bekkers… - Circulation, 2000 - Am Heart Assoc
Background—Nebivolol is a β1-selective adrenergic receptor antagonist with proposed nitric
oxide (NO)–mediated vasodilating properties in humans. In this study, we explored whether …

The endothelium in health and disease: a discussion of the contribution of non-nitric oxide endothelium-derived vasoactive mediators to vascular homeostasis in …

CR Triggle, H Ding, TJ Anderson… - Molecular and cellular …, 2004 - Springer
Endothelial dysfunction is considered as a major risk factor of cardiovascular complications
of type I and types II diabetes. Impaired endothelium-dependent vasodilatation can be …

Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes

R Fogari, A Zoppi, P Lazzari, A Mugellini… - Journal of human …, 1997 - nature.com
The aim of this double-blind, parallel group study was to compare the effects of nebivolol
and atenolol on blood pressure (BP) and insulin sensitivity in hypertensive patients with type …

Nebivolol induces calcium-independent signaling in endothelial cells by a possible β-adrenergic pathway

W Gosgnach, C Boixel, N Névo… - Journal of …, 2001 - journals.lww.com
Nebivolol is a highly selective β 1-adrenoreceptor-blocking agent with a peculiar
pharmacodynamic profile. It has peripheral acute vasodilating properties that are mediated …